SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-22-007760
Filing Date
2022-03-31
Accepted
2022-03-31 07:06:09
Documents
14
Period of Report
2022-03-30
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K gnpx20220330_8k.htm   iXBRL 8-K 26631
2 EXHIBIT 99.1 ex_352914.htm EX-99.1 17659
  Complete submission text file 0001437749-22-007760.txt   185928

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA gnpx-20220330.xsd EX-101.SCH 3602
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gnpx-20220330_def.xml EX-101.DEF 11917
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE gnpx-20220330_lab.xml EX-101.LAB 15957
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gnpx-20220330_pre.xml EX-101.PRE 12128
8 EXTRACTED XBRL INSTANCE DOCUMENT gnpx20220330_8k_htm.xml XML 2639
Mailing Address 1601 TRINITY STREET, BLDG. B SUITE 3.322 AUSTIN TX 78712
Business Address 1601 TRINITY STREET, BLDG. B SUITE 3.322 AUSTIN TX 78712 512-537-7997
Genprex, Inc. (Filer) CIK: 0001595248 (see all company filings)

IRS No.: 900772347 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38244 | Film No.: 22789096
SIC: 2834 Pharmaceutical Preparations